The third conferences of the series Drug Discovery & Therapy World Congress 2015 (DDTWC 2015) and the Global Biotechnology Congress 2015 (GBC 2015),were organized by Eureka Conferences, Inc., and again held in Boston, at the John B. Hynes Memorial Convention Center, from 22nd – 25thJuly, 2015. These parallel held international symposia gathered more than 600 pharmaceutical scientists, doctors, clinical researchers and biotechnologists to elucidate on the latest discoveries and researches in their respective fields.
This year the events proved much larger with over 330 talks delivered in various sessions of drug discovery and biotechnology.
TRACKS OF THE CONFERENCE (DDTWC 2015)
The inaugural ceremony marked the commencement of these august events on 22nd July 2015, seeking to provide eminent scientists the opportunity to present their cutting edge researches in the field of drug development and discovery and the applications in medicine and biotechnology.
Prof. Dr. Atta-ur-Rahman, the Co-President of DDTWC 2015 and GBC 2015 extended a very warm welcome to the honorable Nobel Laureates, leading scientists and young researchers participating in these two symposia which are organized each year to offer an in-depth assessment of the challenges involved in the dynamic and fast moving field of drug discovery and development as well as biotechnology.
DDTWC 2014 and GBC 2014 welcomed leading chemists, pharmacologists, biotechnologists and other associated professionals to discuss and present the latest important developments in their respective fields from various regions of the world.
In comparison to last year, there was a significant increase in the number of participants from North America, being 33% as against 11% in 2014, which is a proof enough of the recognition of these successful events amongst the developed countries.
The two simultaneously held symposia, DDTWC 2015 and GBC 2015, offered successive Plenary lectures, Keynote lectures, Invited and Session lectures in various fields, disseminating the advancements and researches in diverse fields of medicine and biotechnology to over 650 participants. A total of 10 plenary lectures were delivered by Dr. Pamela Silver, Dr. Phillip sharp (Nobel Laureate), Prof. FeridMurad (Nobel Laureate), Dr. Martin Nowak, Dr. Bernard Palsson, Dr. Charles Serhan, Dr. ShujiOgino, Dr. Ada Yonath (Nobel Laureate), Dr. Edmond Yunis and Dr. Richard Atkinson.
Each day the lecture sessions commenced with the Plenary lectures delivered by renowned scientists and biotechnologists, followed by Keynote, Invited and Session lectures held in 7, 6, 5 and 4 parallel sessions on Days 1, 2, 3 and 4, respectively.
The exhibition of DDTWC 2015 and GBC 2015 was another appealing aspect which proceeded in full swing on all four days of the conferences. The major exhibitors were the following:
The sponsors and media partners of DDTWC and GBC 2014 were the following:
Another center of attraction of the events was the Poster presentation session which was held on the 24th and 25th of July 2015, proffering an opportunity to mostly young scientists to present theirresearch endeavors through the conventional printed posters besides the E-posters. Those prospective who could physically ensure their presence in the conference were offered the option to deliver E-posters, which were facilitated through online interactive session between the poster presenter and the attendees. The poster presenters put forward an array of over 150 proficiently prepared posters which were very well received and garnered a lot of attention and discussion by the participants of the events.
The Organizers acknowledged the efforts of the poster presenters by rewarding one best poster for each conference with a monetary prize.
Eureka Conferences, Inc.,continued with their trend to hold the relatively new series of conferences of Drug Discovery and Therapy World Congress 2015 and Global Biotechnology Congress 2015 the third successive year, which proved appreciably successful. DDTWC 2015 and GBC 2015 were held at the John B. Hynes Memorial Convention Center, Boston, MA, USA from 22nd – 25th July, 2015. These conferences presented thoroughly enlightening plenary, keynote, invited and session lectures delivered over 41 thematic sessions in the drug discovery fields and 8 thematic sessions on the biotechnology front along with poster presentations and an associated commercial exhibition.
An array of distinguished scientists and researchers from all over the world enthusiastically participated in these symposia to present their share of researches to the delegates craving for information on breakthroughs in diverse fields of science and technology.
The conferences drew a curtain on the 25th of July 2015 to be raised again next year in August 2016.
Eureka Conferences, Inc. recently organised the Drug Discovery & Therapy World Congress 2014 (DDTWC 2014) and the Global Biotechnology Congress 2014 (GBC 2014), in Boston, at the John B. Hynes Memorial Convention Center, from 16th – 19th June, 2014. These international conferences provided a platform for an in-depth assessment of the challenges involved in the dynamic field of drug discovery and development as well as biotechnology.
TRACKS OF DRUG DISCOVERY & THERAPY WORLD CONGRESS 2014
The opening session of DDTWC 2014 and GBC 2014 was jointly held on 16th June 2014 and marked the inauguration of these symposia of multidimensional importance, seeking to highlight the importance and significance of the latest research advances in the field of drug discovery, disease management and diagnosis as well as the translational nature of biotechnological research.
In the augural address, Prof. Dr. Atta-ur-Rahman extended a very warm welcome to the honorable Nobel Laureates, leading scientists and young researchers participating in these two symposia.
DDTWC 2014 and GBC 2014 brought together leading chemists, pharmacologists, biotechnologists and other allied professionals to discuss and present the latest important developments in the fields from various regions of the world.
The two conferences presented a series of Plenary, Keynote, Invited and Session lectures in various fields, catering to a gathering of over 500 participants. A total of 12 plenary lectures were delivered by Dr. Allan L. Goldstein, Dr.Antonio M. Gotto, Jr., Dr. Debomoy K. Lahiri, Dr. Richard Lee Atkinson, Hiroshi Maeda, Dr. William B. Weglicki, Dr. Shuji Ogino, Edmond J. Yunis, Dr. Lee M. Kaplan, Dr. Vladimir Torchilin, Dr. Mary-Elizabeth Patti and Dr. Muhammad Iqbal Choudhary.
Each day the lecture sessions commenced with the Plenary lectures given by renowned scientists and biotechnologists, and were later taken over by a large number of eminent researchers who presented their talks as Invited and Session lectures.
The exhibition of DDTWC and GBC 2014 was another appealing aspect which proceeded in full swing on all four days of the conferences. The major exhibitors were the following:
The sponsors and media partners of DDTWC and GBC 2014 were the following:
To present more information on the breakthrough developments in the two respective areas, two hours were allotted on the 18th and 19th of June 2014 for the Poster Session. The poster presenters put forward an array of over 150 proficiently prepared posters which were very well received and garnered a lot of attention and discussion by the participants of the events.
The Organizers acknowledged the efforts of the poster presenters by rewarding one best poster for each conference with a monetary prize.
Drug Discovery and Therapy World Congress 2014 and Global Biotechnology Congress 2014 were held at the John B. Hynes Memorial Convention Center, Boston, MA, USA from 16th – 19th June, 2014. These conferences presented plenary, keynote, invited and session lectures delivered over 41 thematic sessions in the drug discovery fields and 8 thematic sessions in the biotechnology front along with poster presentations and an associated commercial exhibition.
The conferences provided the renowned scientists an excellent opportunity to present their cutting edge researches in their respective fields from this platform.
Ferid Murad (Nobel Laureate)
George Washington University, Washington D.C, USA
Jean-Marie LEHN (Nobel Laureate)
ISIS - Universite de Strasbourg, Alsace, France
Gannu Praveen Kumar
St. Peter’s Institute of Pharmaceutical Sciences, Andhra Pradesh, India
Maha Hammad
The University of Western Ontario, Ontario, Canada
Rakesh Kumar
George Washington University, Washington DC, USA
Faikah Gueler
Hannover Medical School, Hannover, Germany
Beka Solomon
University of Tel Aviv, Ramat Aviv, Israel
I wish to congratulate and thank the organizing team for their efforts and achievements.
Fazlul Huq
The University of Sydney, Sydney, Australia
On a different matter, I would prefer the dinner on the boat than the one in the desert.
Debomoy K. Lahiri
Institute of Psychiatric Research, USA
Prof. Antonio Gotto, Jr.
Lewis Thomas University, USA
Dr. Rathnam Chaguturu
University of Kansas, Lawrence, KS, USA
Eureka Conferences, Inc. proudly announced the Drug Discovery & Therapy World Congress 2013 (DDTWC 2013) as well as World Biotechnology Congress (WBC 2013), which were held at the John B. Hynes Memorial convention Center, Boston, MA, USA from January 3rd – 6th June, 2013. To keep the trend of spreading the scientific researches and biotechnological advancements alive, throughout the world, Eureka Conferences, Inc., in the USA, sought to offer an in-depth assessment of the challenges involved in the dynamic and fast moving field of drug discovery and development as well as biotechnology, and bring together leading chemists, pharmacologists, biotechnologists, and other allied professionals to discuss and present the latest important developments in the fields.
DDTWC 2013 was unique in disseminating translational characteristics of recent biomedical and pharmaceutical research, with both scientists and clinicians associated with either patient care or with drug discovery research. This symposium provided a forum to highlight the developments in human molecular medicine with the explicit provisions for the drug discovery process. The congress was based on the following tracks.
On the other hand, WBC 2013 was exceptional in endorsing the breakthroughs in the Biotechnology field and drew together both novice and veterans from the biotechnological front from all over the world to present the innovations and advancements in the biotechnology sphere both at regional and global level. The congress reviewed the best current research and non-commercial aspects of the field. The major areas of biotechnology were classed on the basis given below.
In the augural address, Dr. Rakesh Kumar, a distinguished professor in Biotechnology, on behalf of the President of Drug Discovery and Therapy World Congress 2013 (DDTWC 2013) and the World Biotechnology Congress (WBC 2013), Dr. Ferid Murad (a renowned Nobel Laureate), who could unfortunately not make it to these events, extended a very warm welcome to the honourable Nobel Laureates, leading scientists and young researchers participating in these two grand symposia.
A total of 8 Plenary lectures were delivered for a joint Plenary session of DDTWC 2013 and WBC 2013 namely by Dr. Antonio M. Gotto, Dr. Allan L. Goldstein, Dr. Rudolf Jaenisch, Dr. Richard Lee Atkinson, Sir Alan Fersht, Dr. Paul Greengard (Nobel Laureate), Dr. Karl Barry Sharpless (Nobel Laureate) and Dr. Edmond J. Yunis.
Similarly, a number of Keynote lectures were presented by Dr. William Weglicki, Dr. Kristi L Helke, Dr. Rathnam Chaguturu, Dr. Attilio Di Pietro, Dr. Caroline M. Apovian, Dr. Robert J. Linhardt, Dr. Barry Springer, Dr. Mark G. Moloney, Dr. Jeffrey Ulmer, Dr. Dimiter S. Dimitrov, Dr. Paul Imbach and Evan Y. Snyder.
There were a total of 350 Registrants on the list of World Biotechnology Congress 2013 as against slightly more than 350 for Drug Discovery and Therapy World Congress 2013.
Each day commenced with 2 Plenary lectures, followed by keynote, invited and session lectures. The platform of WBC 2013 presented 8 Invited whereas 127 Session lectures. On the contrary, DDTWC 2013 set the stage for 12 Invited and 148 Session lectures.
The conferences proffered an incredible opportunity to basic research, clinical findings and practices in the various thematic sessions along with poster sessions, covering both pre-clinical and clinical research in drug discovery and therapy as well as all the major areas of biotechnology,
To ensure that the participants do not miss out the poster sessions, one hour was allotted each day to the poster sessions after the lectures. WBC 2013 held a meticulous poster session of 140 posters. Similarly, DDTWC 2013 exhibited around 135 posters.
The poster presenters displayed their skillfully created and enthusiasticlly organized posters, which attracted a large number of delegates to acknowledge the efforts of the presenters.
The winding up of the conference presented the Cash Distribution Ceremony which was the most sought after event of this conference, rewarding one best poster for each conference. A panel of judges shouldered the responsibility to assess all the posters very critically, finally awarding the best poster which geared up immense interest amongst the participants.